BETAMETHASONE\CALCIPOTRIENE: 119 Adverse Event Reports & Safety Profile
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
119
Total FAERS Reports
3 (2.5%)
Deaths Reported
48
Hospitalizations
119
As Primary/Secondary Suspect
3
Life-Threatening
3
Disabilities
First Report: 20120404 · Latest Report: 20240101
What Are the Most Common BETAMETHASONE\CALCIPOTRIENE Side Effects?
#1 Most Reported
Drug ineffective
34 reports (28.6%)
#2 Most Reported
Psoriasis
33 reports (27.7%)
#3 Most Reported
Medication error
22 reports (18.5%)
All BETAMETHASONE\CALCIPOTRIENE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 34 | 28.6% | 0 | 13 |
| Psoriasis | 33 | 27.7% | 0 | 0 |
| Medication error | 22 | 18.5% | 0 | 22 |
| Depressed mood | 14 | 11.8% | 0 | 12 |
| Dizziness | 14 | 11.8% | 0 | 12 |
| Dyspnoea | 13 | 10.9% | 0 | 12 |
| Off label use | 13 | 10.9% | 0 | 11 |
| Bradycardia | 12 | 10.1% | 0 | 12 |
| Hypertension | 12 | 10.1% | 0 | 11 |
| Wound haemorrhage | 12 | 10.1% | 0 | 12 |
| Abdominal discomfort | 11 | 9.2% | 0 | 11 |
| Amnesia | 11 | 9.2% | 0 | 11 |
| Blood pressure inadequately controlled | 11 | 9.2% | 0 | 11 |
| Cognitive disorder | 11 | 9.2% | 0 | 11 |
| Contusion | 11 | 9.2% | 0 | 11 |
| Diabetes mellitus inadequate control | 11 | 9.2% | 0 | 11 |
| Exercise tolerance decreased | 11 | 9.2% | 0 | 11 |
| Guttate psoriasis | 11 | 9.2% | 0 | 0 |
| Mobility decreased | 11 | 9.2% | 0 | 11 |
| Oedema peripheral | 11 | 9.2% | 0 | 10 |
Who Reports BETAMETHASONE\CALCIPOTRIENE Side Effects? Age & Gender Data
Gender: 60.5% female, 39.5% male. Average age: 59.8 years. Most reports from: JP. View detailed demographics →
Is BETAMETHASONE\CALCIPOTRIENE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2012 | 8 | 0 | 1 |
| 2013 | 1 | 0 | 0 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 0 |
| 2016 | 4 | 0 | 2 |
| 2017 | 5 | 0 | 0 |
| 2018 | 3 | 0 | 3 |
| 2019 | 1 | 0 | 0 |
| 2020 | 4 | 2 | 1 |
| 2021 | 3 | 1 | 1 |
| 2022 | 15 | 0 | 11 |
| 2023 | 4 | 0 | 1 |
| 2024 | 1 | 0 | 0 |
What Is BETAMETHASONE\CALCIPOTRIENE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 53 |
| Psoriasis | 49 |
| Pruritus | 7 |
| Psoriatic arthropathy | 5 |
BETAMETHASONE\CALCIPOTRIENE vs Alternatives: Which Is Safer?
BETAMETHASONE\CALCIPOTRIENE vs BETASERON
BETAMETHASONE\CALCIPOTRIENE vs BETAXOLOL
BETAMETHASONE\CALCIPOTRIENE vs BETHANECHOL
BETAMETHASONE\CALCIPOTRIENE vs BEVACIZUMAB
BETAMETHASONE\CALCIPOTRIENE vs BEVACIZUMAB-AWWB
BETAMETHASONE\CALCIPOTRIENE vs BEVACIZUMAB-BVZR
BETAMETHASONE\CALCIPOTRIENE vs BEVACIZUMAB-MALY
BETAMETHASONE\CALCIPOTRIENE vs BEXAROTENE
BETAMETHASONE\CALCIPOTRIENE vs BEZAFIBRATE
BETAMETHASONE\CALCIPOTRIENE vs BEZLOTOXUMAB
Official FDA Label for BETAMETHASONE\CALCIPOTRIENE
Official prescribing information from the FDA-approved drug label.